Abid Irshad

Concepts (117)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mammography
9
2017
310
1.890
Why?
Breast Neoplasms
9
2018
1536
1.130
Why?
Ultrasonography, Mammary
5
2015
39
1.080
Why?
Practice Guidelines as Topic
2
2017
772
0.810
Why?
Breast Density
3
2017
21
0.760
Why?
Radiology
3
2018
97
0.700
Why?
Carcinoma, Hepatocellular
2
2012
163
0.660
Why?
Liver Cirrhosis
2
2012
301
0.620
Why?
Liver Neoplasms
2
2012
334
0.590
Why?
Quality Assurance, Health Care
1
2016
177
0.510
Why?
Graft Rejection
2
2009
458
0.510
Why?
Image Interpretation, Computer-Assisted
1
2016
237
0.480
Why?
Practice Patterns, Physicians'
1
2017
504
0.430
Why?
Ultrasonography, Doppler
2
2009
57
0.410
Why?
Biliary Dyskinesia
1
2011
7
0.400
Why?
Kidney Transplantation
2
2009
839
0.370
Why?
Diagnostic Imaging
2
2008
201
0.320
Why?
Kidney Diseases
2
2009
307
0.320
Why?
World Health Organization
1
2008
53
0.310
Why?
International Classification of Diseases
1
2008
85
0.310
Why?
Granular Cell Tumor
1
2008
9
0.310
Why?
Abdomen
1
2008
80
0.300
Why?
Lymphoma
1
2008
116
0.290
Why?
Ultrasonography
5
2012
453
0.290
Why?
Observer Variation
2
2018
330
0.280
Why?
Breast Diseases
2
2016
40
0.250
Why?
Middle Aged
13
2017
21147
0.240
Why?
Carcinoma, Small Cell
1
2004
53
0.240
Why?
Carcinoma, Ductal, Breast
2
2015
62
0.230
Why?
Female
17
2018
38074
0.220
Why?
Humans
22
2018
68618
0.220
Why?
Receptors, Progesterone
2
2013
57
0.210
Why?
Receptors, Estrogen
2
2013
142
0.200
Why?
Receptor, ErbB-2
2
2013
129
0.200
Why?
Postoperative Complications
1
2009
1615
0.200
Why?
Sensitivity and Specificity
3
2016
1753
0.200
Why?
Positron-Emission Tomography
2
2011
160
0.180
Why?
Magnetic Resonance Imaging
3
2015
2223
0.180
Why?
Adult
11
2017
21403
0.170
Why?
Mass Screening
2
2017
843
0.160
Why?
Cancer Care Facilities
1
2018
32
0.160
Why?
Carcinoma in Situ
1
2018
47
0.150
Why?
Arterial Occlusive Diseases
2
2009
134
0.150
Why?
Diagnostic Errors
1
2018
100
0.150
Why?
Mobile Health Units
1
2017
18
0.150
Why?
Absorptiometry, Photon
1
2016
83
0.140
Why?
Referral and Consultation
1
2018
383
0.130
Why?
Neoplasm Invasiveness
2
2018
369
0.130
Why?
Reproducibility of Results
3
2016
2077
0.130
Why?
Medical Oncology
1
2016
110
0.130
Why?
Lung Neoplasms
1
2004
1173
0.130
Why?
Guideline Adherence
1
2016
287
0.120
Why?
Ovarian Cysts
1
2013
9
0.120
Why?
Ultrasonography, Doppler, Color
1
2013
21
0.110
Why?
Diagnosis, Differential
3
2013
1140
0.110
Why?
Aged, 80 and over
6
2016
4848
0.110
Why?
Research Design
1
2017
729
0.110
Why?
Neoplasm Grading
1
2013
111
0.110
Why?
Tomography, X-Ray Computed
2
2013
2324
0.100
Why?
Biomarkers, Tumor
2
2013
508
0.100
Why?
Sentinel Surveillance
1
2012
20
0.100
Why?
Gallbladder Emptying
1
2011
4
0.100
Why?
Imino Acids
1
2011
7
0.100
Why?
ROC Curve
1
2013
392
0.100
Why?
Cholecystokinin
1
2011
29
0.100
Why?
Ovarian Neoplasms
1
2013
267
0.100
Why?
Technetium
1
2011
38
0.100
Why?
Aged
8
2017
14862
0.100
Why?
Pelvic Pain
1
2011
11
0.100
Why?
Ascitic Fluid
1
2009
22
0.090
Why?
Neoplasm Staging
2
2012
800
0.090
Why?
Imaging, Three-Dimensional
1
2011
333
0.090
Why?
Paracentesis
1
2009
25
0.090
Why?
Ascites
1
2009
38
0.090
Why?
Analysis of Variance
1
2011
1040
0.080
Why?
Predictive Value of Tests
1
2013
1465
0.080
Why?
Rare Diseases
1
2008
41
0.080
Why?
Disease Progression
1
2012
1038
0.080
Why?
Urethral Obstruction
1
2008
8
0.080
Why?
Retrospective Studies
6
2018
7277
0.080
Why?
Male
4
2012
37321
0.080
Why?
Contrast Media
1
2011
595
0.080
Why?
Statistics as Topic
1
2008
219
0.080
Why?
Radiography, Abdominal
1
2008
57
0.070
Why?
United States
2
2018
7367
0.070
Why?
Chronic Disease
1
2012
1330
0.070
Why?
Biopsy
2
2018
540
0.060
Why?
Neoplasm Recurrence, Local
1
2007
446
0.060
Why?
Abdominal Neoplasms
1
2004
22
0.060
Why?
Thoracic Neoplasms
1
2004
10
0.060
Why?
Kidney
1
2009
945
0.060
Why?
Prospective Studies
1
2011
3705
0.060
Why?
Bone Neoplasms
1
2004
100
0.060
Why?
Brain Neoplasms
1
2004
371
0.050
Why?
National Cancer Institute (U.S.)
1
2018
35
0.040
Why?
Follow-Up Studies
2
2018
3259
0.040
Why?
Genetic Testing
1
2018
159
0.040
Why?
Premenopause
1
2016
57
0.030
Why?
Postmenopause
1
2016
93
0.030
Why?
Calcinosis
1
2016
241
0.030
Why?
Ovary
1
2013
99
0.030
Why?
Early Detection of Cancer
1
2017
454
0.030
Why?
Mesenteric Lymphadenitis
1
2011
2
0.020
Why?
Ureteral Calculi
1
2011
4
0.020
Why?
Diverticulitis
1
2011
6
0.020
Why?
Intestinal Obstruction
1
2011
36
0.020
Why?
Appendicitis
1
2011
55
0.020
Why?
Colitis
1
2011
156
0.020
Why?
Pregnancy Complications
1
2011
286
0.020
Why?
Mastectomy, Segmental
1
2007
64
0.020
Why?
Risk Factors
1
2017
5731
0.020
Why?
Brachytherapy
1
2007
79
0.020
Why?
Biopsy, Needle
1
2007
191
0.020
Why?
Pregnancy
1
2011
2334
0.020
Why?
Child
1
2013
6405
0.010
Why?
Adolescent
1
2013
8912
0.010
Why?
Treatment Outcome
1
2007
7029
0.010
Why?
Irshad's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (117)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_